I. Alarcón

FRI0306 IDIOPATHIC INFLAMMATORY MYOPATHIESAND ANTISYNTHETASE SYNDROME: CONTRIBUTION OF ANTISYNTHETASE ANTIBODIES TO IMPROVE CURRENT CLASSIFICATION CRITERIA

L. Carmona, E. Loza, M. J. García de Yébenes, 2019, Scleroderma, myositis and related syndromes.

Effectiveness of different methods for anti-Sm antibody identification. A multicentre study

J. Gónzalez-Buitrago, Concepción González, J. Jiménez, 2005, Clinical chemistry and laboratory medicine.

Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria

L. Carmona, E. Loza, M. J. García de Yébenes, 2019, Annals of the rheumatic diseases.

Antinuclear antibodies (ANA) screening by enzyme immunoassay with nuclear HEp-2 cell extract and recombinant antigens: analytical and clinical evaluation.

Concepción González, M. Hernando, J. Navajo, 2002, Clinical biochemistry.

Large Evaluation of Anti-Cardiolipin and anti-β2 Glycoprotein I Assays: Results from the Autoimmunity Workshop of the Spanish Society of Immunology

R. Pastor, A. Serrano, M. López-Hoyos, 2009 .

Antisynthetase antibodies in clinical laboratories: the importance of clinical correlation and indirect immunofluorescence. Response to: Comment on: ‘Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria’

L. Carmona, E. Loza, M. J. García de Yébenes, 2019, Annals of the Rheumatic Diseases.

AB0656 ANTISYNTHETASE SYNDROME: CLINICAL VALUE OF SOLOMON’S AND CONNORS’ DIAGNOSIS CRITERIA

L. Carmona, E. Loza, T. Otón, 2019, Abstracts accepted for Publication.

AB0657 ANTISYNTHETASE SYNDROME: NON-ANTISYNTHETASE ANTIBODIES, CLINICAL MANIFESTATIONS AND OVERLAPS

L. Carmona, E. Loza, T. Otón, 2019, Abstracts accepted for Publication.